Abstract
Immunological hyporesponsiveness (anergy) is a concomitant of diseases due to intracellular pathogens and well-demonstrated in tuberculosis. The expression of anergy in tuberculosis encompasses depression of both delayed-type hypersensitivity (DTH), manifest as depressed tuberculin skin test reaction, and in vitro lymphocyte responses to antigens of Mycobacterium tuberculosis. Evidence for immunosuppression, which appears to be mostly limited to mycobacterial antigens, has been documented in different populations with active tuberculosis worldwide, regardless of prior BCG vaccination status. Whether attenuation of the host responses to antigens of M. tuberculosis that stimulate or maintain protective immunity is a factor in the development of tuberculosis or contributes to the chronicity of the disease is not known. However, it appears that anergy in active tuberculosis is mediated largely through monocytes that display signs of activation, possibly by exposure to mycobacterial antigens or cytokines in situ. M. tuberculosis and its constituents are potent in stimulation of monocytes to produce an array of cytokines, notably transforming growth factor β (TGF-(β), which is suppressive to lymphocytes, deactivates macrophage effector functions, and promotes fibrosis (Wahl 1992). Immunosuppressive circuits are activated in situ as newly recruited monocytes encounter M. tuberculosis and its products; at the site of infection these circuits may contribute to immunopathogenesis, while at local sites of exposure to antigens (skin test) they may modulate the expression of DTH.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahuja SS, Paliogianni F, Yamada H, Balow JE, Boumpas DT (1993) Effect of transforming growth factor-p on early and late activation events in human T cells. J Immunol 150: 3109–3118
Andrade-Arzabe R, Machado IV, Fernndez B, Blanca I, Ramirez R, Bianco NE (1991) Cellular immunity in current active pulmonary tuberculosis. Am Rev Respir Dis 143: 496–500
Barnes PF, Mistry SD, Cooper CL, Cooper CL, Pirmez C, Rea TH, Modlin RL (1989) Compartmenta-lization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 142: 1114–1119
Barnes PF, Fong F-J, Brennan PJ, Twomey PE, Mazumuder A, Modlin RL (1990) Local production of TNFa and IFNy in tuberculous pleuritis. J Immunol 145: 149–154
Barnes PF, Mehra V, Rivoire B, Fong SJ, Brennan PJ, Voegtline PM, Houghten RA, Bloom BR, Modlin RL (1992a) Immunoreactivity of a 10 kD antigen of Mycobacterium tuberculosis. J Immunol 148: 1835–1840
Barnes PF, Grisso CL, Abram JF, Band H, Rea TM, Modlin RL (1992b) yS T-lymphocytes in human tuberculosis. J Infect Dis 165: 506–512
Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL (1993) Cytokine production at the site of disease in human tuberculosis. Infect Immun 61: 3482–3489
Bhatnagar R, Malaviya AN, Naray Anan P, Ragopalan P, Kumar R, Bharadwaj OP (1977) Spectrum of immune response abnormalities in different clinical forms of tuberculosis. Am Rev Respir Dis 115: 207–212
Border WA, Rusolahti ER (1992) Transforming growth factor ß in disease: the dark side of tissue repair. J Clin Invest 90: 1–7
Brabletz T, Pfeuffer I, Schorr E, Siebelt F, Wirth T, Serfling E (1993) Transforming growth factor ß and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a non canonical octamer-binding site. Mol Cell Bio 13: 1155–1162
Brown AE, Reicker TK, Webster HK (1989) Prolonged elevated soluble interleukin-2 receptors in tuberculosis. Am Rev Respir Dis 139: 1036–1038
Canessa PA, Fasano L, Lavecchia MA, Torraca A, Schiattone ML (1989) Tuberculin skin test in asymptomatic HIV seropositive carriers. Chest 96: 1215–1218
Carlucci S, Beschin A, Tuosto L, Ameglio F, Gandolfo GM, Cocito C, Fiorucci F, Saltini C, Piccolella E (1993) Mycobacterial antigen complex A60-specific T cell response during the course of pulmonary tuberculosis. Infect Immun 61(2): 439–447
Centers for Disease Control (1990) Tuberculin reaction in apparently health HIV seropositive and HIVseronegative women: Uganda. MMWR 39: 638–646
Centers for Disease Control (1991) Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 40: 27–38
Comstock GW, Livesay VT, Woolpert SF (1974) The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 99: 131–138
Cox RA, Downs M, Neimes RE, Ognibene AJ, Yamashita TS, Ellner JJ (1988) Immunogenic analysis of human tuberculosis. J Infect Dis 158: 1302–1308
Dahl KE, Shiratsuchi H, Hamilton BD, Ellner JJ, Toossi Z (1996) Selective induction of TGF3 in human monocytes by lipoarabinomannan of M. tuberculosis. Infect Immun 64: 399–405
Daniel TM, Oxtoby MJ, Pinto E, Moreno S (1981) The immune spectrum in patients with pulmonary tuberculosis. Am Rev Respir Dis 123: 556–559
Davis J, Rich RR, Van M, Le MV, Pollach MS, Cook RG (1987) Defective antigen presentation and novel structural properties of DR1 from an HLA haplotype associated with 21-hydroxylase deficiency. J Clin Invest 80: 898–904
Ellner JJ (1978a) Suppressor adherent cells in human tuberculosis. J Immunol 121: 2573–2578
Ellner JJ (1978b) Pleural fluid and peripheral blood lymphocyte function in tuberculosis. Ann Intern Med 89: 932–933
Ellner JJ (1990) Tuberculosis in the times of AIDS. The facts and the message. Chest 98: 1051–1052
Ellner JJ, Spagnuolo PJ, Schacter BZ (1981) Augmentation of selective monocyte functions in tuberculosis. J Infect Dis 144: 391–398
Ellner JJ, Boom WB, Edmonds KL, Rich EA, Toossi Z, Wallis RS (1990) Regulation of the immune response to Mycobacterium tuberculosis. In: Ayoub EM et al. (eds) Microbial determinants of virulence and host response. American Society for Microbiology, Washington DC, pp 77–91
Enelow RI, Sullivan GW, Carper HT, Mandell G (1992) Induction of MGC formation from in vitro culture of human monocytes with IL-3 and IFNy. Comparison with other simulating factors. Am J Respir Cell Mol Biol 6: 57–62
Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, Pallandino MAJr (1987) Inhibition of cytokine production by cyclosporin A and transforming growth factor ß.J Exp Med 166: 571–576
Falla JC, Para CA, Mendoza M, Franco LC, Guzmaan F, Orozco O, Patarroyo ME (1991) Indentification of B and T cell epitopes within the MTP 40 protein of M. tuberculosis and their correlation with the disease course. Infect Immun 59: 2265–2273
Fontana A, Frei K, Bodmer S, Hoefer E, Scheier MH, Pallandino MA, Zingkernagel M (1989) Transforming growth factor-ß inhibits the generation of cytotoxic T cells in virus infected mice. J Immunol 143: 3220–3234
Fujiwara H, Tsuyuguchi I (1984) Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculous pleuritis. Chest 89: 530–535
Fujiwara H, Kleinhenz ME, Wallis RS, Ellner JJ (1986) Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am Rev Respir Dis 133: 73–77
Fullmer MA, Shen J-Y, Modlin RL, Rea TH (1987) Immunohistochemical evidence of lymphokine production and lymphocyte activation antigens in tuberculin reaction. Clin Exp Immunol 67: 383390
Graham NMH, Nelson KE, Solomon L, Bonds M, Rizzo RT, Scavotto J, Astemborski J, Vlahov D (1992) Prevalence of tuberculin positivity and skin test anergy in HIV-1 seropositve and seronegative intravenous drug users. JAMA 267: 369–372
Grzybowski S, Allen EA (1964) The challenge of tuberculosis in decline: a study based on the epidemiology of tuberculosis in Ontario, Canada. Am Rev Respir Dis 90: 707–720
Havlir DV, van der Kupy F, Duffy E, Marshall R, Hom D, Ellner JJ (1991a) A 19 year follow-up of tuberculin reactors: assessment of skin test reactivity and in vitro lymphocyte responses. Chest 99: 1172–1176
Havlir DV, Wallis RS, Boom WH, Daniel TM, Chevernak K, Ellner JJ (1991b) Human immune response to Mycobacterium tuberculosis antigens. Infect Immun 59: 665–670
Havlir DV, Ellner JJ, Chevernak KA, Boom WH (1991c) Selective expansion of human yS T-cells by monocytes infected with live Mycobacterium tuberculosis J Clin Invest 87: 729–733
Heimbeck (1928) Immunity to tuberculosis. Arch Intern Med 41: 336–342
Hirsch CS, Yoneda T, Ellner JJ, Averill LE, Toossi Z (1994) Enhancement of intracellular growth of M. tuberculosis in human monocytes by transforming growth factor beta. J Infect Dis 170: 12291237
Holden M, Dubin MR, Diamond PH (1971) Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med 285: 1506–1509
Hunter SW, Gaylord H, Brennan PJ (1986) Structure and antigenicity of the phosophorylated antigens from leprosy and tubercle bacilli. J Biol Chem 261: 12345–12351
Hussain R, Dawood G, Obaid M, Toossi Z, Wallis RS, Minai A, Dojki M, Sturm AW, Ellner JJ (submitted) Depressed cellular and augmented humoral responses in patients with active tuberculosis from Pakistan.
Huygen K, van Vooren JP, Turneer M, Bosmans R, Dierckx P, De Bruyn J (1988) Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol 27: 187–194
Kay AB, Ying S, Varney V, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q (1991) Messenger RNA expression of the cytokine gene cluster, IL-3, IL-4, IL-5, and GM-CSF in allergen-induced late-phase reactions in atopic subjects. J Exp Med 173: 775–779
Kim SJ, Angel P, Lafyatis R, Hattori K, Kim KY, Spron MB, Karin M, Roberts AB (1990) Autoinduction of transforming growth factor ß1 is mediated by the AP-1 complex. Mol Cell Biol 10: 1492–1496
Kindler V, Syepino AP, Gran GE et al (1989) The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56: 731–740
Kleinhenz ME, Ellner JJ (1985) Immunoregulatory adherent cells in human tuberculosis: radiation-sensitive antigen-specific suppression by monocytes. J Infect Dis 152: 171–176
Kleinhenz ME, Ellner JJ (1987) Antigen responsiveness during tuberculosis: regulatory interaction of T-cells subpopulations and adherent cell. J Lab Clin Med 110: 31–40
Klienhenz ME, Ellner JJ, Spagnulo PJ, Daniel TM (1981) Suppression of lymphocyte responses by tuberculous plasma and mycobacteril arabinogalctan: monocyte dependence and indomethecin reve rs i b i l ity.68: 153–158
Maeda J, Ueki N, Ohkawa T, Iwahashi N, Nakano T, Hada T, Higashino K (1993) Local production and localization of transforming growth factor beta in tuberculous pleurisy. Clin Exp Immunol 92: 32–38
McCartney-Francis NL, Wahl SM (1994) Transforming growth factor ß: a matter of life and death.J Leukoc Biol 55: 401–409
Miller SD, Jones HE (1973) Correlation of lymphocyte transformation with tuberculin skin-test sensitivity. Am Rev respir Dis 107: 530–538
Miyazono K, Heldin CH (1989) Role for carbohydrate structures in TGF-ß 1 latency. Nature 338: 158160
Nsubuga P, Whalen C, Johenson JL, Byekwaso F, Okwera A, Mugerwa R, Ellner JJ (1994) Preserved PPD reactivity and frequent cavitary disease as initial clinical manifestations of pulmonary tuberculosis in HIV-infected Ugandans. International conference on AIDS 1994, 7–12; Aug, Vol 10(2), p 28 (abstact no 406B)
Ogawa T, Uchida H, Kusumoto Y, Mori Y, Yamamura Y, Hamada S (1991) Increase in tumor necrosis factor alpha and interluekin-6 secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun 59: 3021–3025
Onwubalili JK, Scott GM, Robinson JA (1985) Deficient immune interferon production in tuberculosis. Clin Exp Immunol 59: 405–413
Orme IM (1988) Induction of non specific acquired resistance and delayed type hypersensitivity but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun 56: 3310–3312
Orme IM, Collins FM (1984) Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity. Cell Immunol 84: 113–120
Orme IM, Miller ES, Roberts AD (1992) T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterirum tuberculosis infection. J Immunol 148: 189–196
Pal PG, Horowitz MA (1992) Immunization with extracellular proteins of M. tuberculosis induces cell-mediated immune responses with substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun 60(11): 4782–4792
Palmer CE, Edwards LB (1966) The tuberculin test: in retrospect and prospect. The Baker Lecture, presented at the University of Michigan School of Public Health, Ann Arbor, MI
Pesanti EL (1994) The negative tuberculin test. Am J Resp Crit Care Med 149: 1699–1709
Pilatte Y, Bignon J, Lambre CR (1987) Lysosomal and cytosolic sialidases in rabbit alveolar macrophages, demonstration of increased lysosomal activity after in vivo activation with BCG. Biochem Biophys Acta 923: 150–155
Platt JL, Grant BW, Eddy AA, Michael AF (1983) Immune cell populations in cutaneous delayed-type hypersensitivity. J Exp Med 158: 1227–1242
Rooney JJ, Crocco JA, Kramer S, Lyons HA(1976) Further observations on tuberculin reactions in tuberculosis. Am J Med 60: 517–522
Salata RA, Sanson AJ, Malhotra IJ, Wiker HG, Harboe M, Philips NB, Daniel TM (1991) Purification and characterization of the 30,000 dalton native antigen of Mycobacterium tuberculosis and characterization of six monoclonal antibodies reactive with a major epitope of this antigen. J Lab Clin Med 118: 589
Schmitt E, Meuret G, Stix L (1977) Monocyte recruitment in tuberculosis and sarcoidosis. Br J Haematol 35: 11–17
Shiratsuchi H, Okuda Y, Tsuyuguchi I (1987) Recombinant human IL-2 reverses in vitro deficient cell-mediated immune responses to tuberculin purified derivative by lymphocytes of tuberculous patients. Infect Immun 55: 2126–2131
Sieling PA, Abrams JS, Yamamura M, Salgame P, Bloom BR, Rea TH, Modlin RL (1993) Immunosuppressive roles for IL-10 and IL-4 in human infection. J Immunol 150: 5501–5510
Stead WW (1969) The new face of tuberculosis. Hosp Prac 4: 62
Stead WW (1981) Tuberculosis among elderly persons: an outbreak in a nursing home. Ann Intern Med 94: 606–610
Street NE, Mossman TR (1991) Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 5: 171–175
Surcel HM, Tory-Blomberg M, Paulie S, Anderson G, Moreno C, Pasvol G, Ivanyi J (1994) TH1/TH2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 81: 171–176
Takashima T, Ueta C, Tsuyuguchi I, Kishimoto S (1990) Production of tumor necrosis factor by monocytes from patients with pulmonary tuberculosis. Infect. Immun 58: 3286–3292
Tazi A, Bouchonnet F, Valeyre O, Battesti JP, Hance AJ (1992) Characterization of 78 T lymphocytes in the peripheral blood of patients with active tuberculosis. Am Rev Respir Dis 146: 1216–1221
Theuer CP, Hopewell PC, Elias D, Schecter GF, Rutherford GW, Chaisson RF (1990) Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis 162: 8–12
Toossi Z, Kleinhenz ME, Ellner JJ (1986) Defective interleukin-2 production and responsiveness in human pulmonary tuberculosis. J Exp Med 163: 1162–1172
Toossi Z, Edmonds KE, Tomford WJ, Ellner JJ (1989) Suppression of PPD-induced interleukin-2 production by interaction of CD 16 lymphocytes and adherent mononuclear cells in tuberculosis. J Infect Dis 159: 352–356
Toossi Z, Lapurga JP, Ondash R, SedorJr, Ellner JJ (1990) Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. J Clin Invest 85: 1777–1784
Toossi Z, Sierra-Madero JG, Blinkhorn RA, Mettler MA, Rich EA (1993) Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus. J Exp Med 177: 1511–1517
Toossi Z, Young TG, Averill LE, Hamilton BD, Shiratsuchi H, Ellner JJ (1995a) Induction of Transforming growth factor-p (TGF-ß) by purified protein derivative (PPD) of mycobacterium tuberculosis. Infect Immun 63: 224–228
Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ (1995b) Enhanced production of transforming growth factor-ß (TGF-J) by blood monocytes from patients with active tuberculosis and presence of TGFp in tuberculous granlomatous lung lesions. J Immunol 154: 465–473
Toossi Z, Hirsch CS, Hamilton BD, Knuth CK, Friedlander MA, Rich EA (1996) Decreased production of transforming growth factor 01 (TGF-ß1) in human alveolar macrophages. J Immunol (in press)
Torres M, Mendez-Sampiero P, Jimenez-Zamudio L, Teran L, Camerena A, Quezada R, Ramos E, Sada E (1994) Comparison of the immune response against Mycobacterium tuberculosis antigens between a group of patients with active pulmonary tuberculosis and healthy household contacts. Clin Exp Immunol 96: 75–78
Tsicopoulos A, Hamid Q, Varney V, Ying V, Moqbel R, Durham SR, Kay AB (1992) Preferential messenger RNA expression of Th1-type cells (IFN gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol 148: 2058–2061
Tsunawki S, Spron M, Nathan C (1988) Deactivation of macrophages by TGF 3. Nature 334: 260–264
Tsuyuguchi I, Kawasumi H, Ueta C, Yano I, Kishimoto S (1991) Increase of T-Cell Receptor gamma/delta-bearing T cells in cord blood of newborn babies obtained by in vitro stimulation withmycobacterial cord factor. Infect Immun 59: 3053–3059
Tweardy DJ, Schacter BZ, Ellner JJ (1984) Association of altered dynamics of monocyte surface expression of human leukocyte antigen-DR with immunosuppression in tuberculosis. J Infect Dis 149: 31–37
Valone SE, Rich EA, Wallis RS, Ellner J (1988) Expression of Tumor Necrosis Factor In Vitro by human mononuclear phagocytes stimulated with whole mycobacterium bovis BCG and mycobacterial antigens. Infect Immun 56: 3313–3315
Vanham G, Edmonds KE, Qing L, Hom D, Toossi Z, Joness B, Daley C, Huebner R, Kestens L, Gigase P, Ellner JJ (submitted) Global immune activation during M. tuberculosis infection in humans.
Vilcek J, Klion A, Henriksen-DeStefano D, Zemtsov A, Davidson DM, Davidson M, Friedman-Kien A (1986) Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis. J Clin Immunol 6: 146–151
Vordemeier HM, Harris DP, Friscia G, Roman E, Surcel HM, Moreno C, Pasvol G, lvanyi J (1992) T cell repertoire in tuberculosis: Selective energy to an immunodominant epitope of the 380kDa antigen in patients with active disease. Eur J Immunol 22: 2631–2637
Wahl S (1992) Transforming growth factor Beta: a cause and a cure. J Clin Immunol 2: 61–71
Wallis RS, Fujiwara H, Ellner JJ (1986) Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens. J Immunol 136: 193–196
Wallis RS, Paranjape R, Phillips M (1993) Identification by two-dimensional gel electrophoresis of a 58kilodalton tumor necrosis factor-inducing protein of Mycobacterium tuberculosis. Infect Immun 61: 627–632
Welch GR, Wong HL, Wahl SM (1990) Selective induction of Fc gamma RIII on human monocytes by transforming growth factor P. J Immunol 144: 3444–3448
Wu CY, Demeure C, Kiniwa M, Gately M, Delepess G (1993) IL-2 induces the production of IFN-y by neonatal human CD4 T cells. J Immunol 151: 1938–1949
Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254: 277–279
Zhang M, Gately MK, Modlin RL, Barnes PF (1994) Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 93: 1733–1739
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Toossi, Z., Ellner, J.J. (1996). Mechanisms of Anergy in Tuberculosis. In: Shinnick, T.M. (eds) Tuberculosis. Current Topics in Microbiology and Immunology, vol 215. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80166-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-80166-2_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80168-6
Online ISBN: 978-3-642-80166-2
eBook Packages: Springer Book Archive